Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer.

Abstract excerpt

Somatic mutations reported in large-scale breast cancer (BC) sequencing studies primarily consist of protein coding mutations. mRNA splicing mutation analyses have been limited in scope, despite their prevalence in Mendelian genetic disorders. We predicted splicing mutations in 442 BC tumour and matched normal exomes from The Cancer Genome Atlas Consortium (TCGA). These splicing defects were validated by abnormal...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alternative Splicing
• Share to CD56 Antigen
• Share to Databases, Nucleic Acid